ACE and myocardial infarction: The percentage of patients with a history of myocardial infarction (from 1 April 2011 {from 1 October 2009 for the purposes of piloting} currently treated with an ACE inhibitor, aspirin or an alternative anti-platelet therapy, beta-blocker and statin (unless a contraindication or side effects are recorded)